Project Grant R01HL169147
Award Date
7/10/24
Completion Date
6/30/28
Dollars Obligated
$706K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $2,508,095 to Yale University to conduct research on the underlying mechanisms of thoracic aortic disease. The overarching goal is to elucidate how aberrant interactions between vascular cells and the extracellular matrix lead to the progressive deterioration of the thoracic aorta, potentially resulting in aortic dilatation, dissection,...
This $1,927,989 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to understand the molecular mechanisms and develop novel therapeutic approaches for congenital aortic valve disease. The research will utilize a newly developed mouse model that recapitulates the human condition of congenital aortic valve stenosis. The objectives are to define the cell-specific pathways underlying...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), supports research under the Cardiovascular Diseases Research program (CFDA 93.837). The $169,560 grant awarded to the Regents of the University of Michigan aims to investigate the role of the PERK/EIF2A/ATF4 endoplasmic reticulum stress response and MLL1-mediated regulation of CHOP gene expression in vascular smooth muscle cell (VSMC) apoptosis and...
This $122,625 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to identify small molecule compounds that can activate the SIRT1 protein and thereby inhibit the progression of aortic aneurysms in Marfan syndrome patients. The key research activities include in silico screening of a molecular library to identify promising SIRT1 activating compounds, followed by in vitro testing of these...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $817,498 in funding to Trustees of Boston University (Boston University Medical Campus) to conduct research on the role of thiol redox signaling in aortic aneurysm development, with a focus on Marfan syndrome. The research aims to investigate how oxidative inactivation of the SIRT1 protein, through glutathionylation, contributes to vascular smooth muscle...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $715,180 in funding to Baylor College of Medicine to study the epigenetic regulation of trained immunity in thoracic aortic aneurysms and dissections. The research aims to: 1) determine the sites and epigenetic signatures of trained immunity in monocytes/macrophages in the aortic wall and bone marrow in animal models and patients; 2) assess...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,944,807 to the University of Colorado (CU) to study the role of inflammation and biological sex on aortic valve fibrocalcification. The research aims to develop in vitro models of sex-specific aortic valve disease progression, investigate the crosstalk between macrophages and valve interstitial cells, and determine the role of...
The federal Project Grant award in the amount of $2,070,048.00 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program. The award supports a comprehensive investigation of the cellular and molecular mechanisms regulating atherosclerotic plaque stability and instability, with the goal of identifying novel therapeutic targets to reduce cardiovascular disease risk. The research program, led by The Trustees of Columbia...
This federal Project Grant award of $686,458, awarded on July 10, 2024 by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports a research project focused on developing a quantitative, predictive model of vascular remodeling in health and disease. The key objective is to acquire quantitative data on the interactions within vascular remodeling regulatory networks and develop a computational model that can accurately...
This federal Project Grant award for $2,395,029.00 from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research on the role of endothelial cell metabolism and cell cycle regulation in mediating the effects of fluid shear stress on vascular health and atherosclerosis risk. The research aims to conduct a thorough unbiased analysis of the differential effects of laminar versus disturbed blood flow on endothelial cell...